Related Experiment Video
Updated: May 27, 2026
Establishment of Orthotopic Patient-derived Xenograft Models for Brain Tumors using a Stereotaxic Device
Published on: May 2, 2025
Novel cell lines established from pediatric brain tumors
Jingying Xu1, Anat Erdreich-Epstein, Ignacio Gonzalez-Gomez
1Developmental Therapeutics Program, Division of Hematology-Oncology, USC-CHLA Institute for Pediatric Clinical Research, Children's Hospital Los Angeles, Los Angeles, CA 90027, USA.
Researchers developed three new pediatric cell lines for studying childhood brain tumors, including glioblastoma, medulloblastoma, and atypical teratoid rhabdoid tumors. These models exhibit unique genetic profiles and drug resistance, offering valuable tools for preclinical therapeutic development.
Area of Science:
- Oncology
- Pediatric Neuro-oncology
- Cell Biology
Background:
- Limited availability of pediatric brain tumor cell culture models hinders research and therapeutic development.
- Establishment of novel cell lines is crucial for understanding tumor biology and testing new treatments.
Purpose of the Study:
- To establish and characterize new pediatric cell lines for glioblastoma (GBM), anaplastic medulloblastoma, and atypical teratoid rhabdoid tumor (AT/RT).
- To evaluate these cell lines for their utility in biological experiments and preclinical therapeutic studies.
Main Methods:
- Establishment of three distinct pediatric cell lines (CHLA-200, CHLA-259, CHLA-266) from patient tumors.
- Characterization using DNA short tandem repeat profiling, morphology, doubling time, TP53 mutation analysis, and drug sensitivity assays (DIMSCAN).
- Gene expression analysis (MYC, MYCN via RT-PCR) and in vivo tumorigenicity studies in NOD/SCID mice.
Main Results:
- Successfully established CHLA-200 (GBM), CHLA-259 (medulloblastoma), and CHLA-266 (AT/RT) cell lines with patient tumor-matched DNA fingerprints.
- CHLA-266 exhibited INI1 deficiency and monosomy 22, consistent with AT/RT. All lines showed relative multi-drug resistance.
- Tumorigenicity varied, with CHLA-259 and CHLA-266 forming tumors in mice, including brain xenografts, and expressing specific markers (GFAP, PGP 9.5).
Conclusions:
- The three newly established pediatric cell lines represent valuable and unique models for childhood brain tumor research.
- These cell lines will facilitate further investigation into the biology of pediatric brain tumors and the development of targeted therapies.
